Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh

• Published in: PloS one 2021-07, Vol.16 (7), p.e0255379-e0255379
• Main Authors: Rahman, Md. Ashrafur, Shanjana, Yeasna, Tushar, Md. Ismail, Mahmud, Tarif, Rahman, Ghazi Muhammad Sayedur, Milan, Zahid Hossain, Sultana, Tamanna, Chowdhury, Ali Mohammed Lutful Hoq, Bhuiyan, Mohiuddin Ahmed, Islam, Md. Rabiul, Reza, Hasan Mahmud
• Format: Article
• Language: English
• Subjects: Abnormalities; Biology and Life Sciences; Blood; C-reactive protein; Care and treatment; Comorbidity; Coronaviruses; Correlation; COVID-19; Data interpretation; Demographics; Demography; Diabetes; Dimers; Ferritin; Health risks; Health services; Hematology; Hospital patients; Medicine and Health Sciences; Mortality; Parameters; Patient outcomes; Patients; Polymerase chain reaction; Statistical analysis; Statistical analysis of data
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0255379

The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual associations between specific blood parameters and COVID-19 are not well understood. Here we aimed to assess the correlations between hematological parameters and the severity of COVID-19. We included COVID-19 patients who were admitted to Evercare Hospital Ltd, Dhaka, Bangladesh, between November 10, 2020, to April 12, 2021, with a confirmed case of RT-PCR test. We recorded demographic information, clinical data, and routine hematological examination results of all COVID-19 patients. We performed statistical analyses and interpretation of data to compare severe COVID-19 patients (SCP) and non-severe COVID-19 patients (NSCP). The age and BMI of the admitted COVID-19 patients were 48.79±8.53 years and 25.82±3.75 kg/m.sup.2 . This study included a total of 306 hospitalized COVID-19 patients. Among them, NSCP and SCP were 198 and 108, respectively. And we recorded 12 deaths from SCP. We observed the alterations of several hematological parameters between SCP and NSCP. Among them, we noticed the increased levels of C-reactive protein (CRP), d-dimer, and ferritin showed good indicative value to evaluate the severity of COVID-19. Also, there were positive correlations among these parameters. Moreover, we found correlations between the outcomes of COVID-19 patients with patient's demographics and comorbid diseases. Based on our results, CRP, d-dimer, and ferritin levels at admission to hospitals represent simple assessment factors for COVID-19 severity and the treatment decisions at the hospital setup. These blood parameters could serve as indicators for the prognosis and severity of COVID-19. Therefore, our study findings might help to develop a treatment protocol for COVID-19 patients at the hospital setup.